These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 35339664)
1. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Rivière B; Jaussent A; Macioce V; Faure S; Builles N; Lefebvre P; Géraud P; Picot MC; Rebuffat S; Renard E; Paradis V; Servais MD; de Preville N; Nocca D; Lajoix AD; Pageaux GP; Galtier F; Diabetes Metab; 2022 Jul; 48(4):101345. PubMed ID: 35339664 [TBL] [Abstract][Full Text] [Related]
2. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659 [TBL] [Abstract][Full Text] [Related]
3. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE. Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197 [No Abstract] [Full Text] [Related]
4. TyG-GGT is a Reliable Non-Invasive Predictor of Advanced Liver Fibrosis in Overweight or Obese Individuals. Jin L; Gu J; Zhang Z; Du CF; Xu FQ; Huang XK; Gao ZY; Li Y; Yu LL; Zhang X; Ru GQ; Liu JW; Liang L; Sun XD; Xiao ZQ Obes Surg; 2024 Apr; 34(4):1333-1342. PubMed ID: 38427150 [TBL] [Abstract][Full Text] [Related]
5. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116 [TBL] [Abstract][Full Text] [Related]
6. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138 [TBL] [Abstract][Full Text] [Related]
7. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity. Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744 [No Abstract] [Full Text] [Related]
8. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery. Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837 [TBL] [Abstract][Full Text] [Related]
11. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women. Simental-Mendía LE; Simental-Mendía E; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F Ann Hepatol; 2016; 15(5):715-20. PubMed ID: 27493110 [TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjects. Newfield RS; Graves CL; Newbury RO; Schwimmer JB; Proudfoot JA; Say DS; Feldstein AE Pediatr Diabetes; 2019 Feb; 20(1):41-47. PubMed ID: 30467936 [TBL] [Abstract][Full Text] [Related]
13. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
14. The HAALT Non-invasive Scoring System for NAFLD in Obesity. Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455 [TBL] [Abstract][Full Text] [Related]
15. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population. Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database. Shelley K; Articolo A; Luthra R; Charlton M BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. Lembo E; Russo MF; Verrastro O; Anello D; Angelini G; Iaconelli A; Guidone C; Stefanizzi G; Ciccoritti L; Greco F; Sessa L; Riccardi L; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G; Gastaldelli A; Capristo E Diabetes Metab; 2022 Sep; 48(5):101363. PubMed ID: 35760372 [TBL] [Abstract][Full Text] [Related]